Targeting glutamine metabolism as a therapeutic strategy for cancer

J Jin, JK Byun, YK Choi, KG Park - Experimental & Molecular Medicine, 2023 - nature.com
Proliferating cancer cells rely largely on glutamine for survival and proliferation. Glutamine
serves as a carbon source for the synthesis of lipids and metabolites via the TCA cycle, as …

Endocytosis in cancer and cancer therapy

B Banushi, SR Joseph, B Lum, JJ Lee… - Nature Reviews …, 2023 - nature.com
Endocytosis is a complex process whereby cell surface proteins, lipids and fluid from the
extracellular environment are packaged, sorted and internalized into cells. Endocytosis is …

[HTML][HTML] Regulation of antioxidants in cancer

F Hecht, M Zocchi, F Alimohammadi, IS Harris - Molecular Cell, 2024 - cell.com
Scientists in this field often joke," If you don't have a mechanism, say it's ROS." Seemingly
connected to every biological process ever described, reactive oxygen species (ROS) have …

To metabolomics and beyond: a technological portfolio to investigate cancer metabolism

F Danzi, R Pacchiana, A Mafficini, MT Scupoli… - … and Targeted Therapy, 2023 - nature.com
Tumour cells have exquisite flexibility in reprogramming their metabolism in order to support
tumour initiation, progression, metastasis and resistance to therapies. These reprogrammed …

Macropinocytosis: mechanisms and regulation

G Salloum, AR Bresnick, JM Backer - Biochemical Journal, 2023 - portlandpress.com
Macropinocytosis is defined as an actin-dependent but coat-and dynamin-independent
endocytic uptake process, which generates large intracellular vesicles (macropinosomes) …

Coupling doping and localized surface plasmon resonance toward acidic pH-preferential catalase-like nanozyme for oxygen-dominated synergistic cancer therapy

Y Rao, G Xu, Z Zhang, W Wang, C Zhang… - Chemical Engineering …, 2023 - Elsevier
Hypoxia increases patient treatment resistance and favors cancer progression. Nanozymes
have received unprecedented attention in alleviating hypoxia via catalase (CAT)-mimicking …

[HTML][HTML] The impact of hypoxia on tumor-mediated bypassing anti-PD-(L) 1 therapy

K Mortezaee, J Majidpoor, E Kharazinejad - Biomedicine & …, 2023 - Elsevier
Extending the durability of response is the current focus in cancer immunotherapy with
immune checkpoint inhibitors (ICIs). However, factors like non-immunogenic tumor …

Hypoxia signaling in cancer: Implications for therapeutic interventions

Y Zhuang, K Liu, Q He, X Gu, C Jiang, J Wu - MedComm, 2023 - Wiley Online Library
Hypoxia is a persistent physiological feature of many different solid tumors and a key driver
of malignancy, and in recent years, it has been recognized as an important target for cancer …

Hypoxia-Responsive lncRNA AC115619 Encodes a Micropeptide That Suppresses m6A Modifications and Hepatocellular Carcinoma Progression

Q Zhang, T Wei, L Yan, S Zhu, W Jin, Y Bai, Y Zeng… - Cancer Research, 2023 - AACR
Long noncoding RNAs (lncRNA) regulate a number of aspects of cancer biology. Recent
research has shown that lncRNAs can encode micropeptides that mediate their functions in …

Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition

Q Chu, J An, P Liu, Y Song, X Zhai, R Yang… - Journal of Experimental …, 2022 - rupress.org
Fatty acid uptake is essential for cell physiological function, but detailed mechanisms remain
unclear. Here, we generated an acetyl-CoA carboxylases (ACC1/2) double-knockout cell …